RADIATION · Unmapped registry intervention
3D-CRT
Find medicine records ·
Find other trials using this name
Clinical trial
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00002602
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
3D-CRTRADIATION
Sponsors & collaborators
Radiation Therapy Oncology Grouplead sponsor
National Cancer Institute (NCI)collaborator
NRG Oncologycollaborator
Mapped research locations
PhiladelphiaPennsylvania, United States6MilwaukeeWisconsin, United States5Los AngelesCalifornia, United States4BaltimoreMaryland, United States4New YorkNew York, United States3ClevelandOhio, United States3PittsburghPennsylvania, United States3New OrleansLouisiana, United States3ChicagoIllinois, United States2St LouisMissouri, United States2AtlantaGeorgia, United States2MiamiFlorida, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002602 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.